文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

碳酸氢钠与氯化钠预防危重患者对比剂相关急性肾损伤的随机对照试验

Sodium Bicarbonate Versus Sodium Chloride for Preventing Contrast-Associated Acute Kidney Injury in Critically Ill Patients: A Randomized Controlled Trial.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论在肾功能稳定的危重患者中,碳酸氢钠水化与等渗氯化钠水化相比,对比剂相关急性肾损伤发生率无显著差异(35.1% vs 33.3%)。

这项前瞻性、双盲、多中心随机对照研究在法国3个ICU纳入307例肾功能稳定且接受血管内对比剂的危重患者,比较0.9%氯化钠与1.4%碳酸氢钠水化(对比剂前1小时3 mL/kg,后6小时1 mL/kg/hr)对对比剂相关急性肾损伤的预防效果。主要终点为对比剂暴露后72小时按急性肾损伤网络标准定义的对比剂相关急性肾损伤。结果显示碳酸氢钠组与氯化钠组发生率相似(35.1% vs 33.3%,绝对风险差-1.8%,95%CI [-12.3% 至 8.9%],P=0.81),肾脏替代治疗需求、ICU住院时间和死亡率均无显著差异。除尿pH外,两组结局无差异,碳酸氢钠的获益即使存在也有限。

要点

  • 在肾功能稳定的危重患者中,碳酸氢钠水化组对比剂相关急性肾损伤发生率为35.1%,氯化钠组为33.3%,绝对风险差-1.8%(95%CI [-12.3% 至 8.9%],P=0.81),无显著差异。
  • 两组肾脏替代治疗需求(碳酸氢钠组3.9% vs 氯化钠组3.2%,P=0.77)、ICU住院时间(23±23.8天 vs 24.7±22.9天,P=0.52)和死亡率(15.9% vs 16.0%,P>0.99)均无显著差异。
  • 碳酸氢钠组输注结束时尿pH高于氯化钠组(6.7±2.1 vs 6.2±1.8,P<0.0001),但未转化为临床获益。
  • 作者认为,在肾功能稳定的ICU患者中,使用碳酸氢钠而非等渗氯化钠预防对比剂相关急性肾损伤的获益即使存在也有限。

适用人群与场景

  • 法国3个ICU中肾功能稳定且接受血管内对比剂媒体的危重患者(n=307)。

诊断标准与关键阈值

  • 对比剂相关急性肾损伤定义为对比剂暴露后72小时符合急性肾损伤网络标准。

处置流程与药物剂量

  • 0.9%氯化钠或1.4%碳酸氢钠水化方案相同:对比剂前1小时输注3 mL/kg,对比剂后6小时以1 mL/kg/hr输注。

研究设计与关键结果

  • 研究为前瞻性、双盲、多中心随机对照研究,纳入307例患者,碳酸氢钠组151例,氯化钠组156例。
  • 主要终点对比剂相关急性肾损伤发生率:氯化钠组33.3%(52例) vs 碳酸氢钠组35.1%(53例),绝对风险差-1.8%(95%CI [-12.3% 至 8.9%],P=0.81)。
  • 肾脏替代治疗需求:氯化钠组3.2%(5例) vs 碳酸氢钠组3.9%(6例),P=0.77。
  • ICU住院时间:氯化钠组24.7±22.9天 vs 碳酸氢钠组23±23.8天,P=0.52。
  • 死亡率:氯化钠组16.0%(25例) vs 碳酸氢钠组15.9%(24例),P>0.99。
  • 输注结束时尿pH:碳酸氢钠组6.7±2.1 vs 氯化钠组6.2±1.8,P<0.0001。

证据类型、等级与局限

  • 证据类型:前瞻性、双盲、多中心随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在肾功能稳定的ICU患者中,使用碳酸氢钠而非等渗氯化钠预防对比剂相关急性肾损伤的获益即使存在也有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To test whether hydration with bicarbonate rather than isotonic sodium chloride reduces the risk of contrast-associated acute kidney injury in critically ill patients.

DESIGN: Prospective, double-blind, multicenter, randomized controlled study.

SETTING: Three French ICUs.

PATIENTS: Critically ill patients with stable renal function (n = 307) who received intravascular contrast media.

INTERVENTIONS: Hydration with 0.9% sodium chloride or 1.4% sodium bicarbonate administered with the same infusion protocol: 3 mL/kg during 1 hour before and 1 mL/kg/hr during 6 hours after contrast medium exposure.

MEASUREMENTS AND MAIN RESULTS: The primary endpoint was the development of contrast-associated acute kidney injury, as defined by the Acute Kidney Injury Network criteria, 72 hours after contrast exposure. Patients randomized to the bicarbonate group (n = 151) showed a higher urinary pH at the end of the infusion than patients randomized to the saline group (n = 156) (6.7 ± 2.1 vs 6.2 ± 1.8, respectively; p < 0.0001). The frequency of contrast-associated acute kidney injury was similar in both groups: 52 patients (33.3%) in the saline group and 53 patients (35.1%) in the bicarbonate group (absolute risk difference, -1.8%; 95% CI [-12.3% to 8.9%]; p = 0.81). The need for renal replacement therapy (five [3.2%] and six [3.9%] patients; p = 0.77), ICU length of stay (24.7 ± 22.9 and 23 ± 23.8 d; p = 0.52), and mortality (25 [16.0%] and 24 [15.9%] patients; p > 0.99) were also similar between the saline and bicarbonate groups, respectively.

CONCLUSIONS: Except for urinary pH, none of the outcomes differed between the two groups. Among ICU patients with stable renal function, the benefit of using sodium bicarbonate rather than isotonic sodium chloride for preventing contrast-associated acute kidney injury is marginal, if any.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Valette X, Desmeulles I, Savary B, et al. Sodium Bicarbonate Versus Sodium Chloride for Preventing Contrast-Associated Acute Kidney Injury in Critically Ill Patients: A Randomized Controlled Trial. Crit Care Med. 2017. PMID: 28181941. doi:10.1097/CCM.0000000000002267

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。